SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001492648-23-000003
Filing Date
2023-10-30
Accepted
2023-10-30 16:31:14
Documents
2
Period of Report
2023-10-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1631
2 POWER OF ATTORNEY poawoodworth.txt EX-24 2945
  Complete submission text file 0001492648-23-000003.txt   6103
Mailing Address C/O NEUROBO PHARMACEUTICALS, INC. 545 CONCORD AVENUE, SUITE 210 CAMBRIDGE MA 02138
Business Address
Woodworth Marshall H (Reporting) CIK: 0001492648 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37809 | Film No.: 231360751

Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Issuer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations